Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.38
+0.21 (0.78%)
Nov 21, 2024, 11:49 AM EST - Market open
Immunovant Employees
Immunovant had 207 employees as of March 31, 2024. The number of employees increased by 43 or 26.22% compared to the previous year.
Employees
207
Change (1Y)
43
Growth (1Y)
26.22%
Revenue / Employee
n/a
Profits / Employee
-$1,560,415
Market Cap
3.87B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ICU Medical | 14,000 |
| Organon & Co. | 10,000 |
| Option Care Health | 7,802 |
| Haemonetics | 3,657 |
| Sotera Health Company | 3,000 |
| Oscar Health | 2,400 |
| Guardant Health | 1,779 |
| Alvotech | 999 |
IMVT News
- 14 days ago - Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 23 days ago - Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves' Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting - GlobeNewsWire
- 2 months ago - Top 2 Health Care Stocks That May Collapse This Quarter - Benzinga
- 2 months ago - Immunovant Provides Update on Graves' Disease Development Program - GlobeNewsWire
- 2 months ago - Immunovant to Host Graves' Disease Program Update on September 9, 2024 - GlobeNewsWire
- 3 months ago - Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging - Seeking Alpha
- 6 months ago - Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024 - GlobeNewsWire
- 8 months ago - Immunovant: Strategic Edge In The Autoimmune Sector (Rating Upgrade) - Seeking Alpha